Vaccine vial maker Stevanato raises $672 million in U.S. IPO Reuters 2 hrs ago By Echo Wang © Reuters/REMO CASILLI FILE PHOTO: A medical worker at the COVID-19 mass vaccination centre at the Cecchignola military compound, in Rome, Italy
By Echo Wang
NEW YORK (Reuters) - Stevanato Group S.p.A., an Italian maker of glass vials for COVID-19 vaccines and other healthcare products, raised $672 million in a downsized initial public offering on Thursday.
Stevanato said in a statement it priced 32 million shares at $21 per share, compared to its previous plan of 40 million shares at indicated price range of $21 to $24.
The IPO values Stevanato at $6.3 billion.
Italy
Rome
Lazio
Cecchignola
Italian
Cynthia-osterman
Soffieria-stella
Sergio-stevanato
Exchange-commission
Morgan-stanley
York-stock-exchange
Stevanato-group